✦ LIBER ✦

P-15 A phaseII study of bi-weekly paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Kashii, Tatsuhiko; Kasahara, Kazuo; Nishi, Koichi; Kita, Toshiyuki; Oda, Hirofumi; Miwa, Toshiro; Maruyama, Muneharu; Fujimura, Masaki; Nakao, Shinji; Kobayashi, Masashi

Book ID: 118571716
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 178 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91984-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly treatment of non-small-cell lung

Weekly treatment of non-small-cell lung (NSCLC) cancer patients with paclitaxel (P) and carboplatin (C)

✍ Schroeder, M.; Ukena, D.; Schütte, W.; Schröder, R.; Westerhausen, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

P-8 A multicenter phaseII study of carbo

P-8 A multicenter phaseII study of carboplatin/vinorelbine in advanced non-small cell lung cancer(NSCLC) in elderly patients(GFPC 9902)

✍ LeCaer, Hervé; Delhoume, Jean Y.; Thomas, Pascal A.; Berard, Henri; Paillotin, D 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 185 KB

P-469 Weekly paclitaxel (P), carboplatin

P-469 Weekly paclitaxel (P), carboplatin (C) and innotecan (I), PCI, in patients with chemo-naive advanced non-small cell lung cancer (NSCLC)

✍ Chang, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Second-line (SL) weekly paclitaxel (P) i

Second-line (SL) weekly paclitaxel (P) in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing first-line (FL) carboplatin/paclitaxel (C/P)

✍ Socinski, M.A; Kies, M; Unger, P; Peterman, A; Gillenwater, H.H; Schell, M; Bakr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 231 KB

A phase II study of weekly paclitaxel an

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

✍ Andre Michel Kallab; Yasolatha Nalamolu; Paul Maclyn Dainer; Anand Prasad Jillel 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 73 KB

Multi-center study with paclitaxel (P)/c

Multi-center study with paclitaxel (P)/carboplatin (C) in advanced or metastatic non-small cell lung cancer (NSCLC) patients (pts)

✍ Glorieux, P; Ortmanns, P; Marien, S; Degives, R; Degraeve, D; Potvin, M; Grauwel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 206 KB